These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12358849)

  • 41. Effect of amino acid mismatch in the UNOS dataset.
    Sasaki N; El-Awar N; Idica A
    Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
    Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epitope analysis of the HLA class I specific antibodies: a useful tool for the detection of the acceptable mismatches for highly sensitized patients.
    Papassavas AC; Stavropoulos-Giokas C; Boletis J; Iniotaki-Theodoraki A; Ioannou S; Stravoskoufi P; Kostakis A
    Transplant Proc; 2002 Sep; 34(6):2053-5. PubMed ID: 12270311
    [No Abstract]   [Full Text] [Related]  

  • 44. The predictive value of epitope analysis in highly sensitized patients awaiting renal transplantation.
    Laundy GJ; Bradley BA
    Transplantation; 1995 Apr; 59(8):1207-13. PubMed ID: 7537397
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Why can sensitization by an HLA-DR2 mismatch lead to antibodies that react also with HLA-DR1?
    Marrari M; Duquesnoy RJ
    Hum Immunol; 2009 Jun; 70(6):403-9. PubMed ID: 19275922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection and specification of noncomplement binding anti-HLA alloantibodies.
    Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
    Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of Bw4 and Bw6 epitope mismatches on antibody production, acute and chronic rejection, and graft survival in renal allografts.
    Leffell MS; Kraus E; Racusen LC; Ratner LE; Charney D; Zachary AA
    Transplantation; 2001 Aug; 72(3):433-7. PubMed ID: 11502972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Generation of donor-specific anti-human leukocyte antigen antibodies after the transplantation of a fully matched kidney allograft and its impact on the selection of a subsequent renal regraft: a case report.
    Schlaf G; Radam C; Wahle A; Altermann WW
    Transplant Proc; 2012 Jun; 44(5):1442-5. PubMed ID: 22664032
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Critical evaluation of a possible role of HLA epitope matching in kidney transplantation.
    Kumru Sahin G; Unterrainer C; Süsal C
    Transplant Rev (Orlando); 2020 Apr; 34(2):100533. PubMed ID: 32007300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Luminex-based Algorithms to Define Unacceptable HLA Antibodies in CDC-crossmatch Negative Kidney Transplant Recipients.
    Zecher D; Bach C; Preiss A; Staudner C; Utpatel K; Evert M; Jung B; Bergler T; Böger CA; Spriewald BM; Banas B
    Transplantation; 2018 Jun; 102(6):969-977. PubMed ID: 29470350
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human leukocyte antigen class II DQ alpha and beta epitopes identified from sera of kidney allograft recipients.
    Deng CT; El-Awar N; Ozawa M; Cai J; Lachmann N; Terasaki PI
    Transplantation; 2008 Aug; 86(3):452-9. PubMed ID: 18698250
    [TBL] [Abstract][Full Text] [Related]  

  • 52. HLAMatchmaker: a molecularly based algorithm for histocompatibility determination. II. Verification of the algorithm and determination of the relative immunogenicity of amino acid triplet-defined epitopes.
    Duquesnoy RJ; Marrari M
    Hum Immunol; 2002 May; 63(5):353-63. PubMed ID: 11975979
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HLA Epitopes: The Targets of Monoclonal and Alloantibodies Defined.
    El-Awar N; Jucaud V; Nguyen A
    J Immunol Res; 2017; 2017():3406230. PubMed ID: 28626773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mature wines are better: CDC as the leading method to define highly sensitized patients.
    Doxiadis II; Roelen D; Claas FH
    Curr Opin Organ Transplant; 2010 Dec; 15(6):716-9. PubMed ID: 20885325
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human leukocyte antigen epitope antigenicity and immunogenicity.
    Duquesnoy RJ
    Curr Opin Organ Transplant; 2014 Aug; 19(4):428-35. PubMed ID: 25010064
    [TBL] [Abstract][Full Text] [Related]  

  • 57. 16th IHIW: a website for antibody-defined HLA epitope Registry.
    Duquesnoy RJ; Marrari M; da M Sousa LC; de M Barroso JR; de S U Aita KM; da Silva AS; do Monte SJ
    Int J Immunogenet; 2013 Feb; 40(1):54-9. PubMed ID: 23136897
    [TBL] [Abstract][Full Text] [Related]  

  • 58. First report on the antibody verification of HLA-ABC epitopes recorded in the website-based HLA Epitope Registry.
    Duquesnoy RJ; Marrari M; Mulder A; Sousa LC; da Silva AS; do Monte SJ
    Tissue Antigens; 2014 Jun; 83(6):391-400. PubMed ID: 24828056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of HLA-matched blood transfusion for patients awaiting renal transplantation.
    Magee BA; Martin J; Cole MP; Morris KG; Courtney AE
    Transplantation; 2012 Dec; 94(11):1111-6. PubMed ID: 23111496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lights and shadows of anti-HLA antibodies detected by solid-phase assay.
    Picascia A; Sabia C; Grimaldi V; Montesano ML; Sommese L; Schiano C; Napoli C
    Immunol Lett; 2014 Nov; 162(1 Pt A):181-7. PubMed ID: 25171913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.